25-Hydroxycholesterol exacerbates vascular leak during acute lung injury
Jennifer H. Madenspacher,Eric D. Morrell,Jeffrey G. McDonald,Bonne M. Thompson,Yue Li,Konstantin G. Birukov,Anna A. Birukova,Renee D. Stapleton,Aidin Alejo,Peer W. Karmaus,Julie M. Meacham,Prashant Rai,Carmen Mikacenic,Mark M. Wurfel,Michael B. Fessler
DOI: https://doi.org/10.1172/jci.insight.155448
IF: 9.4958
2023-04-11
JCI Insight
Abstract:Cholesterol-25-hydroxylase (CH25H), the biosynthetic enzyme for 25-hydroxycholesterol (25HC), is most highly expressed in the lung, but its role in lung biology is poorly defined. Recently, we reported that Ch25h is induced in monocyte-derived macrophages recruited to the airspace during resolution of lung inflammation and that 25HC promotes liver X receptor–dependent (LXR-dependent) clearance of apoptotic neutrophils by these cells. Ch25h and 25HC are, however, also robustly induced by lung-resident cells during the early hours of lung inflammation, suggesting additional cellular sources and targets. Here, using Ch25h –/– mice and exogenous 25HC in lung injury models, we provide evidence that 25HC sustains proinflammatory cytokines in the airspace and augments lung injury, at least in part, by inducing LXR-independent endoplasmic reticulum stress and endothelial leak. Suggesting an autocrine effect in endothelium, inhaled LPS upregulates pulmonary endothelial Ch25h , and non-hematopoietic Ch25h deletion is sufficient to confer lung protection. In patients with acute respiratory distress syndrome, airspace 25HC and alveolar macrophage CH25H were associated with markers of microvascular leak, endothelial activation, endoplasmic reticulum stress, inflammation, and clinical severity. Taken together, our findings suggest that 25HC deriving from and acting on different cell types in the lung communicates distinct, temporal LXR-independent and -dependent signals to regulate inflammatory homeostasis.
medicine, research & experimental